documents: FDA-2021-N-0874-0088

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-N-0874-0088 FDA FDA-2021-N-0874 September 21, 2023 Endocrinologic and Metabolic Drugs Advisory Committee Intarcia Briefing Document Other Brief 2024-07-31T04:00:00Z 2024 7 2024-07-31T04:00:00Z   2024-07-31T20:10:40Z   0 0 0900006486610463

Links from other tables